Discontinued drugs 2011: endocrine and metabolic

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

(2012) K. H. Yoon et al.   DIABETES OBESITY & METABOLISM

Adenosine A1 receptors do not play a major role in the regulation of lipogenic gene expression in hepatocytes

(2012) Ming Yang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 Diabetes

(2012) R. A. DeFronzo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus

(2012) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: a randomized controlled trial

(2011) Wendy AM Blom et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

(2011) B. Hirshberg et al.   DIABETES CARE

Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists

(2010) Zhicai Yang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1

(2010) Patricia L. Brubaker   ENDOCRINOLOGY

Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-((1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)

(2010) Murielle M. Véniant et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

(2008) N. Anderson et al.   PHARMACOLOGICAL REVIEWS